3
FOR HEALTHCARE PROFESSIONALS
IMPORTANT HEALTH AND SAFETY
INFORMATION:
DO NOT
use the TRUE2go System for patients
receiving the following treatments:
• Peritoneal dialysis using solutions containing
icodextrin (Extraneal
®
, Icodial
®
) that is
metabolized to maltose,
• Injections or infusions of solutions containing
galactose or maltose, including some human
immunoglobulin preparations (Octagam
®
, WinRho
®
,
SDF Liquid, HepaGam B
™
),
• Xylose absorption testing,
• Intravenous solutions containing maltose,
• Any drugs that contain or metabolize to maltose,
galactose, or xylose (Orencia
®
, Adept
®
, Bexxar
®
).
Using the TRUE2go System when receiving
the above treatments may cause false high
glucose results.
2
False high results may lead
to inappropriate therapy, which may result
in coma or death. For more information:
www.fda.gov/BiologicsBloodVaccines/
SafetyAvailability/ucm154213.htm
T2go_OB_GutsENG_F4HDI04.qxd:TT_OB_GutsENG.qxd 1/29/10 10:38 AM Page 3
